A synthetic peptide derived from alpha-fetoprotein inhibits the estradiol-induced proliferation of mammary tumor cells in culture through the modulation of p21

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 463-468

  Sierralta, Walter D ^a   Epuñan, María J ^a   Reyes, José M ^a   Valladares, Luis E ^a   Pino, Ana M ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; ESTRADIOL; SYNTHETIC PEPTIDE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLOPEPTIDE;

ANTINEOPLASTIC ACTIVITY; BINDING SITE; BREAST TUMOR; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG SCREENING; FEMALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY;

MUS;

ALPHA-FETOPROTEINS; ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESTRADIOL; FEMALE; HUMANS; MICE; MICE, SCID; PEPTIDES, CYCLIC; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 46749121834     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_45     Document Type: Conference Paper

References (21)

1. Sommer S, Fuqua SA (2001) Oestrogen receptor and breast cancer. Sem Cancer Biol 11:339-352.
2. Tsai M, O'Malley BW (1994) Molecular mechanism of action of steroid/thyroid superfamily members. Ann Rev Biochem 63:451-486.
3. Batistuzzo de Madeiros SR, Krey G, Hihi AK, et al. (1997) Functional interaction between the estrogen receptor and the transcription factor Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 promoter. J Biol Chem 272:18250-18260.
4. Bates SE, Davidson NE, Valverius EM, et al. (1998) Expression of transforming growth factoralpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its posssible functional significance. Mol Endocrinol 2:543-555.
5. Huynh H, Yang X, Pollak M (1996) Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cell. J Biol Chem 271:1016-1021.
6. Kato S, Endoh H, Masuhiro Y, et al. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein-kinase. Science 270:1491-1494.
7. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. (2000) Interaction of estrogen receptor with the regulatory subunit of phophatidylinositol-3-OH kinase. Nature 407:538-541.
8. Santen RJ, Song RX, MacPherson R, et al. (2002) The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80:239-256.
9. Levin ER (2002) Cellular functions of plasma membrane estrogen receptors. Steroids 67:471-475.
10. Santen (2002) To block estrogen's synthesis or action: that is the question. J Clin Endo Met 87:3007-3012.
11. Gradishar WJ, Jordan VC (1997) Clinical potential of new antie-strogens. J Clin Oncol 15:840-852.
12. Jacobson HI, Thompson WD, Janerich DT (1989) Multiple births and maternal risk of breast cancer. Am J Epidemiol 129:865-873.
13. Jacobson HI, Bennet JA, Mizejewski GJ (1990) Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol. Cancer Res 50:415-420.
14. DeFreest LA, Mesfin FB, Joseph L, et al. (2004) Synthethic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization. J Pept Res 63:409-419.
15. Bennett JA, DeFreest L, Anaka I, et al. (2006) AFPep: an anti-breast cancer peptide that is orally active. Breast Cancer Res Treat 98:133-141.
16. Doisneau-Sixou SF, Sergio CM, Carroll JS, et al. (2003) Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocrine-Related Cancer 10:179-186.
17. Bennett JA, Mesfin FB, Andersen TT, et al. (2002) A peptide derived from α-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen. Proc Natl Acad Sci USA 99:2211-2215.
18. Planas-Silva MD, Weinberg RA (1997) Estrogen-dependent cyclin E-Cdk2 activation through p21 redistribution. Mol Cell Biol 17:4059-4069.
19. Margueron R, Licznar A, Lazennec G, et al. (2003) Oestrogen receptor α?increases p21WAF1/CIP1 gene expression and the antiproliferative activity of histone acetylase inhibitors in human breast cancer cells. J Endocrinol 179:41-53.
20. Hattinger CM, Jochemsen AG, Tanke HJ, et al. (2002) Induction of p21 mRNA synthesis after short-wavelength UV light visualized in individual cells by RNA FISH. J Histochem Cytochem 50:81-89.
21. Parikh RR, Gildener-Leapman N, Narendran A, et al. (2005) Prevention of n-methyl-Nnitrosourea- induced breast cancer by alpha-fetoprotein (AFP)-derived eptide, a peptide derived from the active site of AFP. Clin Cancer Res 11:8512-8520.